News about "cancer cells"

Chugai Pharmaceutical Secures Global First Approval for Lunsumio' Polivy Combo in Relapsed Large B-Cell Lymphoma

Chugai Pharmaceutical Secures Global First Approval for Lunsumio' Polivy Combo in Relapsed Large B-Cell Lymphoma

Japan’s health ministry approves the first in world combination of Lunsumio and Polivy, showing strong response rates and reduced disease progression risk in relapsed or refractory lymphoma patients.

Cancer Cells | 24/03/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members